Attached files

file filename
EX-31 - EX 31.2 SEC 302 CERT - CFO - PARALLAX HEALTH SCIENCES, INC.ex312section302certification.htm
EX-32 - EX 32.1 SEC 906 CERT - CEO - PARALLAX HEALTH SCIENCES, INC.ex321section906certification.htm
EX-31 - EX 31.1 SEC 302 CERT - CEO - PARALLAX HEALTH SCIENCES, INC.ex311section302certification.htm
EXCEL - IDEA: XBRL DOCUMENT - PARALLAX HEALTH SCIENCES, INC.Financial_Report.xls
10-Q - QUARTERLY REPORT - PARALLAX HEALTH SCIENCES, INC.f20140630prlxform10qfinalcle.htm

EXHIBIT 32.2


CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




I, Calli Bucci, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


(1)

the Quarterly Report on Form 10-Q of Parallax Health Sciences, Inc. (formerly Endeavor Power Corp.) for the period ended June 30, 2014 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Parallax Health Sciences, Inc. (formerly Endeavor Power Corp.).






/s/ Calli Bucci

Calli Bucci

Chief Financial Officer


August 19, 2014






A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Parallax Health Sciences, Inc. (formerly Endeavor Power Corp.) and will be retained by Parallax Health Sciences, Inc. (formerly Endeavor Power Corp.) and furnished to the Securities and Exchange Commission or its staff upon request.